eMedicine Specialties > Emergency Medicine > Infectious Diseases

Rabies

Author: Mark A Merlin, DO, EMT-P, FACEP, Assistant Professor, EMS Medical Director, Department of Emergency Medicine, University of Medicine and Dentistry-Robert Wood Johnson Medical School; Medical Director, New Jersey EMS/Disaster Medicine Fellowship, New Jersey EMS Physician Response Program, New Jersey EMS Task Force; Chair of New Jersey Mobile Intensive Care Unit Advisory Council, New Jersey Department of Health and Senior Services
Coauthor(s): Peter W Pryor II, MD, MPH, Fellow in Emergency Medical Services/Disaster Medicine, Attending Physician, Department of Emergency Medicine, Robert Wood Johnson University Hospital, University of Medicine and Dentistry of New Jersey; John Bertolini, MD, Chair, Department of Emergency Medicine, Union Hospital; Raffi Kapitanyan, MD, Assistant Professor, Assistant Professor of Emergency Medicine, Emergency Medicine, Robert Wood Johnson University Hospital/UMDNJ
Contributor Information and Disclosures

Updated: May 11, 2009

Introduction

Background

Rabies is a viral disease of the central nervous system (CNS); it is one of the oldest and most feared diseases reported in medical literature. Incidence of rabies is widespread throughout the world.

Human rabies cases have been documented on all continents except Australia and the Antarctic. Many cases are unreported (or greatly underreported) in developing countries.

Since control of canine rabies in the 1940s and 1950s, human rabies in the United States has become very rare. However, with recent raccoon rabies epizootic in the United States and high transmissibility of the rabies virus by bats, a fear of reemergence of rabies in humans continues to exist. Practicing physicians must understand the biology, pathogenesis, and epidemiology of the disease. Physicians also must have detailed knowledge regarding postexposure prophylaxis for patients who may have been exposed to the disease through animal contact.

Pathophysiology

Most rabies viruses belong to the genus Lyssavirus and the family Rhabdoviridae. They are bullet-shaped RNA viruses with an incubation period of 5 days to 1 year, with an average of 20-90 days. In some cases, the incubation period has been thought to be significantly longer than 1 year.

Susceptibility to infection appears to be related to several factors, including size of inoculum, size and depth of bite, and proximity to the CNS.

Since 1980, most patients with human rabies in the United States have not had definite exposure through a bite wound, making total understanding of the mechanism of transmission somewhat elusive.

After inoculation, viral glycoprotein attaches to the nicotinic acetylcholine receptor of skeletal muscle. Initial replication occurs in myocytes. The virus then enters the nervous system via unmyelinated sensory and motor terminals. At this point, the virus is sequestered from the immune system, and vaccination can no longer be effective. The exact time course of these events is unknown because incubation may take years.

Rabies spreads via retrograde axoplasmic flow at 8-20 mm/d until it reaches the spinal cord. Paresthesias then may begin at the wound site. Rabies continues to spread throughout the CNS, subsequently undergoing centrifugal spread along peripheral nerves to the skin, intestine, and into salivary glands, where it is shed in saliva.

Transmission

The risk of contracting rabies from a bite wound is 5-80%, depending on incidence of rabies in endemic species or other terrestrial animals in the region. Cases from nonbite exposures now are more common in the United States than bite exposures. Unfortunately, most patients with rabies are interviewed after encephalitis symptoms have begun, which complicates ascertaining history. Nonbite exposures include being scratched, being licked over an open wound or mucus membrane, or exposure to brain tissue or cerebrospinal fluid (CSF) of a rabid animal. Nonbite exposures from bats are the exception, and respiratory exposure from bats is a growing concern.

Rabies prophylaxis is now recommended for any routine contact with at-risk animals. Intact skin contact with urine, blood, or feces of an animal has not been shown to constitute exposure, except in bats.

Rodents and lagomorphs (eg, hares) seldom carry rabies, and their bites generally do not require postexposure prophylaxis. Woodchucks are an exception and have been shown to carry rabies. Contacting local or state health departments may be helpful when risk of rabies from a species in a specific geographic region is unknown. The 24-hour/7-day Centers for Disease Control and Prevention (CDC) clinician phone number is (877) 554-4625.

Direct human-to-human transmission of rabies has not been documented. However, 8 cases have been reported in which people died of rabies after transplantation of corneas from people who were diagnosed with the disease. All 8 occurred in transplanted corneas in 5 countries. Only one case was within the United States. Strict corneal transplant regulations are in place to prevent this occurrence.

Frequency

United States

In 2007, 49 states and Puerto Rico reported 7,258 cases of rabies in animals and 1 case in a human (Minnesota) to the CDC, which represents a 4.6% increase from the 6,940 cases in animals and 3 cases in humans reported in 2006. Approximately 93% of the cases were in wildlife and 7% were in domestic animals. To date, raccoons, followed by bats, are the most frequent primary vectors in the eastern United States, with 2659 (36.6%) cases of rabid raccoons and 1,973 (27.2%) cases of bats reported in 2007.1  However, only one case of documented human rabies in the United States is associated with the raccoon rabies variant. Lack of spread of raccoon rabies variant to humans is attributed to domestic animal immunization programs and rapid postexposure prophylaxis of bites to humans. On the other hand, during 2000-2007, 72% of human rabies cases were associated with suspected exposure to rabid bats or infection with bat rabies virus variants.2  Skunk epizootics appear to be widespread in north-central and south-central United States and California.

In an attempt to control animal rabies, rabies vaccine–laden baits have been used in trials in the wild. A Florida trial published in 2000 showed that 57% of raccoons, 85% of opossums, and 50% of gray foxes trapped in a baited area had ingested the bait.3 Recent studies have demonstrated the efficacy of a square presentation of the vaccinia vectored glycoprotein vaccine baits (V-RG) on the red fox, domestic dogs, and raccoon dogs.4

From 1980-2003, 40 cases of human rabies have been documented in the United States by the CDC, although this number is controversial based on questionable cases from other agencies. The animal sources in these cases have included predominantly bats and nondomestic dogs. Other animals rarely include skunks, foxes, and raccoon (one case). 

In the 12 cases associated with dogs, actual exposure occurred outside of the United States, most commonly in Mexico. A total of 19 of the 34 reported cases (1997) have been associated with bats. The silver-haired bat (Lasionycteris noctivagans) accounted for 13 (68%) of 19 bat-related rabies cases. This bat is found throughout the United States, except in the southern coastal regions; it lives in trees and shrubs and can migrate overseas. In a study of 7047 bats in New YorkState, only 25 (0.4%) were silver-haired, and only 2 of these were rabid. These low figures are difficult to reconcile with the high incidence of the silver-haired bat rabies variant in documented human cases. History of a bite wound has only been documented in 1 of the 19 cases of bat-related human rabies. Eight of the remaining cases reported physical contact. No history of bat contact could be found for the remaining 10 cases.

The method of virus transmission in cases with no history of bat contact is unclear. Aerosolization of viral particles, unrecognized scratches or bites, and transmission through another animal species (eg, skunk, raccoon) of the bat rabies variant are possibilities.

From January to August 1997, 2 rabies cases were identified in the United States. Both cases were bat-related, with one occurring in Washington and the other in Montana. In neither case was a bite or definite contact with a bat reported. One case involved a viral strain found in the silver-haired bat, and the other was a variant associated with the big brown bat species; this was the first human rabies fatality involving the big brown bat. In 1996, 4 cases of human rabies were reported. Two cases involved nonbite exposure to the silver-haired bat, and 2 cases involved dog bites that occurred outside the United States.

A total of 18 cases were reported from 1980-1993, 6 cases were reported in 1994, 4 cases were reported in 1995, 4 cases were reported in 1996, and 3 cases were reported in 1997.

A total of 15 cases of human rabies have occurred in the time frame of 2003-2008. Three of these were recipients of solid organ transplants from a single individual. In 2004, 4 recipients of solid organ transplants from a common individual died from encephalitis of unknown source. It was later concluded that the recipients were infected with rabies virus from the donor. Since the successful treatment in 2004 of an unvaccinated infected patient with the Wisconsin rabies treatment protocol, which involved a drug-induced coma and antiviral drugs, no further successes have been reported.5 Two cases in 2006 attempted this treatment protocol in the United States but were unsuccessful.6 The most recent human rabies exposure was in Minnesota in 2007 (no human exposures in 2008), where investigators determined that the likely source was a bat.7  

International

Worldwide, canine rabies variants are still epidemic and a major source of human rabies. The World Health Organization (WHO) in 2004 estimates that as many as 55,000 deaths occur from rabies annually, with 56% in Asia and 44% in Africa.8

Mortality/Morbidity

Although rabies is considered to be a uniformly fatal disease, 3 cases of survival were reported in the 1970s. No additional survival cases have been reported in the 1980s and 1990s. These 3 cases involved patients who were given duck embryo vaccine or suckling mouse brain vaccine before onset of clinical symptoms. Three additional cases of survival, which were not clearly documented, were reported in the 1940s, 1950s, and 1960s.

An additional case in Wisconsin was reported in 2004; a 15-year-old adolescent girl survived rabies without preexposure or postexposure prophylaxis. The girl was bitten by a bat 1 month prior and was given intravenous ribavirin and kept comatose for 7 days. She has partially recovered. As stated above, this is the sixth known case of human recovery from rabies; however, this is the first patient who did not receive rabies prophylaxis either before or after the onset of symptoms.5

Sex

No sex predilection for rabies exists.

Age

No age predilection for rabies exists.

Clinical

History

Suspicion of rabies is clear when a history of an animal bite is given; however, because a history of an animal bite is obtained in less than one half of US cases, diagnosis is problematic. Presentation of a patient in the rabies prodromal stage without a clear exposure history is so nonspecific and rare that making the diagnosis in the ED is essentially impossible. Rabies progresses over 7-14 days, and the mean time between initial presentation and death is 16.2 days.

  • Prodrome
    • Patients have presented to EDs with nonspecific fevers and pharyngitis.
    • Most prodromes last from 2-10 days.
    • Initial symptoms of pain or paresthesias at the site of bite or scratch begin during the prodrome. These are the only symptoms that specifically may raise the red flag of a rabies diagnosis.
    • Fever, headache, and anorexia also may be present.
  • Neurologic stage (2-7 d)
    • Aphasia
    • Incoordination
    • Paresis
    • Paralysis
    • Mental status changes
    • Hyperactivity
  • Late symptoms

Physical

  • High fevers with rapidly progressive encephalitis
  • Myoclonus
  • Increased lacrimation
  • Hypersalivation
  • Agitation
  • Anxiety

Causes

Rabies is transmitted by contact with the rabies virus, although the method of virus transmission may be unclear in cases with no history of contact with the source animal.

More on Rabies

Overview: Rabies
Differential Diagnoses & Workup: Rabies
Treatment & Medication: Rabies
Follow-up: Rabies
Multimedia: Rabies
References

References

  1. Blanton JD, Palmer D, Christian KA, Rupprecht CE. Rabies surveillance in the United States during 2007. J Am Vet Med Assoc. Sept 15 2007;233(6):884-97. [Medline].

  2. Blanton JD, Hanlon CA, Rupprecht CE. Rabies surveillance in the United States during 2006. J Am Vet Med Assoc. Aug 15 2007;231(4):540-56. [Medline].

  3. Olson CA, Mitchell KD, Werner PA. Bait ingestion by free-ranging raccoons and nontarget species in an oral rabies vaccine field trial in Florida. J Wildl Dis. Oct 2000;36(4):734-43. [Medline].

  4. Cliquet F, Guiot AL, Schumacher C, Maki J, Cael N, Barrat J. Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dogs and raccoon dog. Dev Biol (Basel). 2008;131:257-64. [Medline].

  5. Hu WT, Willoughby RE Jr, Dhonau H, Mack KJ. Long-term follow-up after treatment of rabies by induction of coma. N Engl J Med. Aug 30 2007;357(9):945-6. [Medline].

  6. CDC. Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Human rabies--Minnesota, 2007. Ann Emerg Med. Nov 2008;52(5):537-9; discussion 539-40. [Medline].

  7. CDC. Human rabies--Minnesota, 2007. MMWR Morb Mortal Wkly Rep. May 2 2008;57(17):460-2. [Medline].

  8. WHO. WHO expert consultation on rabies. First Report. WHO technical report series. 2004;931:1-121. [Full Text].

  9. Anderson LJ, Nicholson KG, Tauxe RV, Winkler WG. Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann Intern Med. May 1984;100(5):728-35. [Medline].

  10. Barr F. Rabies vaccination. Vet Rec. Jun 16 2007;160(24):850. [Medline].

  11. CDC. Current recommendations for diagnosis of rabies. MMWR Morb Mortal Wkly Rep. 1996;46:27-8.

  12. CDC. Human death associated with bat rabies--California, 2003. MMWR Morb Mortal Wkly Rep. Jan 23 2004;53(2):33-5. [Medline].

  13. CDC. Human rabies prevention--United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. Jan 8 1999;48(RR-1):1-21. [Medline][Full Text].

  14. CDC. Human rabies--Kentucky and Montana 1996. MMWR Morb Mortal Wkly Rep. May 9 1997;46(18):397-400. [Medline].

  15. CDC. Human rabies--Montana and Washington, 1997. MMWR Morb Mortal Wkly Rep. Aug 22 1997;46(33):770-4. [Medline].

  16. CDC. Investigation of rabies infections in organ donor and transplant recipients--Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep. Jul 9 2004;53(26):586-9. [Medline].

  17. CDC. Rabies in a laboratory worker-New York. MMWR Morb Mortal Wkly Rep. 1977;26:1873-82.

  18. CDC. Update on emerging infections from the Centers for Disease Control and Prevention. Update rabies postexposure prophylaxis guidelines. Ann Emerg Med. May 1999;33(5):590-7. [Medline].

  19. CDC. Update: raccoon rabies epizootic--United States and Canada, 1999. MMWR Morb Mortal Wkly Rep. Jan 21 2000;49(2):31-5. [Medline][Full Text].

  20. Chabala S, Williams M, Amenta R, Ognjan AF. Confirmed rabies exposure during pregnancy: treatment with human rabies immune globulin and human diploid cell vaccine. Am J Med. Oct 1991;91(4):423-4. [Medline].

  21. Childs JE, Trimarchi CV, Krebs JW. The epidemiology of bat rabies in New York State, 1988-92. Epidemiol Infect. Dec 1994;113(3):501-11. [Medline].

  22. Fishbein DB. Rabies in humans. In: Baer GM, ed. The Natural History of Rabies. 2nd ed. CRC Press; 1991:519-49.

  23. Fishbein DB, Robinson LE. Rabies. N Engl J Med. Nov 25 1993;329(22):1632-8. [Medline].

  24. Helmick CG. The epidemiology of human rabies postexposure prophylaxis, 1980-1981. JAMA. Oct 21 1983;250(15):1990-6. [Medline].

  25. Krebs JW, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1999. J Am Vet Med Assoc. Dec 15 2000;217(12):1799-811. [Medline].

  26. Krebs JW, Smith JS, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1996. J Am Vet Med Assoc. Dec 15 1997;211(12):1525-39. [Medline].

  27. Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, et al. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. May 23 2008;57:1-28. [Medline].

  28. Mattner F, Bitz F, Goedecke M, Viertel A, Kuhn S, Gastmeier P. Adverse effects of rabies pre- and postexposure prophylaxis in 290 health-care-workers exposed to a rabies infected organ donor or transplant recipients. Infection. Aug 2007;35(4):219-24. [Medline].

  29. MMWR. Human rabies prevention--United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. Jan 8 1999;48(RR-1):1-21. [Medline][Full Text].

  30. Murphy FA. Rabies pathogenesis. Arch Virol. 1977;54(4):279-97. [Medline].

  31. Presutti RJ. Bite wounds. Early treatment and prophylaxis against infectious complications. Postgrad Med. Apr 1997;101(4):243-4, 246-52, 254. [Medline].

  32. Shill M, Baynes RD, Miller SD. Fatal rabies encephalitis despite appropriate post-exposure prophylaxis. A case report. N Engl J Med. May 14 1987;316(20):1257-8. [Medline].

  33. Uhaa IJ, Dato VM, Sorhage FE, Beckley JW, Roscoe DE, Gorsky RD, et al. Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons. J Am Vet Med Assoc. Dec 15 1992;201(12):1873-82. [Medline].

  34. Warrell MJ. Human deaths from cryptic bat rabies in the USA. Lancet. Jul 8 1995;346(8967):65-6. [Medline].

  35. Willoughby RE Jr, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. Jun 16 2005;352(24):2508-14. [Medline].

Further Reading

Keywords

rabies, animal bite, treatment, symptoms, causes, human rabies, rabies vaccine, hydrophobia, mad dog disease, bat rabies, avian rabies, paralytic rabies, dumb rabies, furious rabies, rabies virus, rhabdovirus, Rhabdoviridae, Lyssavirus, human rabies immune globulin, rabies vaccination, postexposure prophylaxis for rabies 

Contributor Information and Disclosures

Author

Mark A Merlin, DO, EMT-P, FACEP, Assistant Professor, EMS Medical Director, Department of Emergency Medicine, University of Medicine and Dentistry-Robert Wood Johnson Medical School; Medical Director, New Jersey EMS/Disaster Medicine Fellowship, New Jersey EMS Physician Response Program, New Jersey EMS Task Force; Chair of New Jersey Mobile Intensive Care Unit Advisory Council, New Jersey Department of Health and Senior Services
Mark A Merlin, DO, EMT-P, FACEP is a member of the following medical societies: American College of Emergency Physicians, American College of Osteopathic Emergency Physicians, American Medical Association, and American Osteopathic Association
Disclosure: Nothing to disclose.

Coauthor(s)

Peter W Pryor II, MD, MPH, Fellow in Emergency Medical Services/Disaster Medicine, Attending Physician, Department of Emergency Medicine, Robert Wood Johnson University Hospital, University of Medicine and Dentistry of New Jersey
Disclosure: Nothing to disclose.

John Bertolini, MD, Chair, Department of Emergency Medicine, Union Hospital
John Bertolini, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Raffi Kapitanyan, MD, Assistant Professor, Assistant Professor of Emergency Medicine, Emergency Medicine, Robert Wood Johnson University Hospital/UMDNJ
Raffi Kapitanyan, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Robert L Norris, MD, Associate Professor, Department of Surgery; Chief, Division of Emergency Medicine, Stanford University Medical Center
Robert L Norris, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, California Medical Association, International Society of Toxinology, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Eric L Weiss, MD, DTM&H, Director of Stanford Travel Medicine, Medical Director of Stanford Lifeflight, Assistant Professor, Departments of Emergency Medicine and Infectious Diseases, Stanford University School of Medicine
Eric L Weiss, MD, DTM&H is a member of the following medical societies: American College of Emergency Physicians, American College of Occupational and Environmental Medicine, American Medical Association, American Society of Tropical Medicine and Hygiene, Physicians for Social Responsibility, Southeastern Surgical Congress, Southern Association for Oncology, Southern Clinical Neurological Society, and Wilderness Medical Society
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Robert E O'Connor, MD, MPH, Professor and Chair, Department of Emergency Medicine, University of Virginia Health System
Robert E O'Connor, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physician Executives, American Heart Association, American Medical Association, Medical Society of Delaware, National Association of EMS Physicians, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.